Email
Password
Remember meForgot password?
    Log in with Twitter

article imageBiochemist seeks funding for novel cancer treatment Special

By Tim Sandle     Aug 19, 2014 in Health
A biochemist who lost his wife to cancer has spent the past 10 years devoting his life to research. This has led to a device that can examine how cancer spreads. To raise funds for the project, a Kickstarter campaign has been launched.
In 2002, Dr. Jeff Allen, of San Diego, CA, lost his 46-year-old wife and mother of his two sons to cancer. Dr. Allen contacted Digital Journal to explain how this devastating loss has since turned into a life passion for both himself and his sons.
Dr. Allen has worked as an analytical biochemist for more than 20 years. In 2012, Dr. Allen formed a company called TumorGen MDx, LLC. The company is a biotechnology start-up with a mission directed at radically changing the way cancer is treated. The company’s goal is to promote “The Breakthrough” which is to bring focus on human cancer stem cells (CSCs) and how they may play a pivotal role in the spread of cancer (metastasis).
The main focus is what Dr. Allen calls the “Pathway to The Breakthrough.” This involves the development of what he is calling the Cancer Stem Cell Capture Chip™ (CSC3™). This is a new microfluidic device designed to find and capture extremely rare cancer stem cells.
As president and founder of TumorGen MDx, Allen also has the help of his two sons in the development of the new microfluidic device. Specifically, son Alexander, who is pursuing a degree in biology at Cal State San Marcos with a focus on studying viral pathogenic genes, has proven highly valuable in creating the design of TumorGen MDx’s CSC3™ microfluidic device. Son Austin, who is studying for an engineering degree at Mira Costa College, has applied his skills and knowledge of AutoCAD® to help create the CSC3™ microfluidic chip layout.
Funding sources for the development of the CSC3™ microfluidic chip are, of course, the key element in moving forward with this invention. TumorGen MDx has a new GoFundMe.com website available for donations with an initial goal of raising $50,000.
More about biochemist, Cancer, Kickstarter
More news from
Latest News
Top News